Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Intarcia’s Exenatide Implant Rejected Again As US FDA Denies Comparative Safety Argument
Aug 23 2024
•
By
Sue Sutter
FDA has closed the door to approval of Intarcia's ITCA 650. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Product Reviews
More from Pink Sheet